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Introduction {#anae14297-sec-0001}
============

In the past 15 years, point‐of‐care viscoelastic testing of blood coagulation, such as thromboelastography (TEG^**®**^, Haemonetics Corp, Braintree, MA, USA) and rotational thromboelastometry (ROTEM^**®**^, Tem International GmbH, Munich, Germany), has played an increasingly prominent role in the diagnosis and management of the acute coagulopathy of trauma and traumatic bleeding [1](#anae14297-bib-0001){ref-type="ref"}. In particular, it has been used before laboratory tests were available to guide early decisions on blood product transfusion [2](#anae14297-bib-0002){ref-type="ref"}, including triggering a massive transfusion protocol [3](#anae14297-bib-0003){ref-type="ref"}. The functional nature of the tests allows rapid detection of coagulation defects [4](#anae14297-bib-0004){ref-type="ref"}, [5](#anae14297-bib-0005){ref-type="ref"}, as well as early differentiation of treatable pathologies such as clotting factor deficiency, platelet depletion or dysfunction, and fibrinolysis [6](#anae14297-bib-0006){ref-type="ref"}, [7](#anae14297-bib-0007){ref-type="ref"}. This has been recognised in the Association of Anaesthetists of Great Britain and Ireland (AAGBI) guidelines on the use of blood components [8](#anae14297-bib-0008){ref-type="ref"}.

A reduced maximum clot firmness (MCF) has been used as a trigger for administration of blood products [9](#anae14297-bib-0009){ref-type="ref"}, but it can take up to 25--29 min to obtain this measurement [10](#anae14297-bib-0010){ref-type="ref"}. For this reason, some researchers in trauma [10](#anae14297-bib-0010){ref-type="ref"}, [11](#anae14297-bib-0011){ref-type="ref"} and in peri‐operative medicine [12](#anae14297-bib-0012){ref-type="ref"}, [13](#anae14297-bib-0013){ref-type="ref"}, [14](#anae14297-bib-0014){ref-type="ref"} have investigated whether clot firmness at 5 min (A5) or 10 min (A10) are acceptable substitutes. Meyer et al. found A10, but not A5, to correlate better with laboratory tests than MCF [10](#anae14297-bib-0010){ref-type="ref"}, and they suggested that early clot amplitude measurements may in fact '*reflect a more dynamic part of the haemostatic process*' than MCF.

Using an equivalent but larger database of consecutive trauma patients from a regional trauma centre who had ROTEM measurements, we performed a similar analysis on the utility of A5 and A10. Our thesis was that (1) the first available clot firmness measure A5 would correlate with MCF in a similar fashion to A10 and (2) the early clot firmness measures, A5 and A10, would predict the requirement for massive transfusion in a similar way to MCF.

Methods {#anae14297-sec-0002}
=======

This research was approved by the Research Ethics Board of Sunnybrook Health Sciences Centre. Patient consent was deemed unnecessary, as this was an observational study and patients received standard care for the time. Data were anonymised before analysis.

Viscoelastic coagulation testing using a single ROTEM test on admission was performed as a standard of care, in addition to traditional coagulation tests, for all trauma patients between August 2011 and March 2013. These data were recorded along with other clinical information including in‐hospital mortality, Injury Severity Score 2005 (ISS 05) and massive transfusion (defined as 10 units of packed red blood cells within 24 h) [15](#anae14297-bib-0015){ref-type="ref"}, [16](#anae14297-bib-0016){ref-type="ref"}.

We focused on A5, A10 and MCF using the EXTEM assay [10](#anae14297-bib-0010){ref-type="ref"}, [11](#anae14297-bib-0011){ref-type="ref"}, [12](#anae14297-bib-0012){ref-type="ref"}, [13](#anae14297-bib-0013){ref-type="ref"}. We used scatter plots and Spearman correlation coefficients to examine the relationship of A5 and A10 with MCF. We also compared the correlation between these measures and transfusion requirements and mortality using receiver operating characteristic curves and c‐stat values.

The study ended when the loan of the ROTEM machines finished. There was no formal power calculation to determine sample size. We used SAS 9.3 (SAS Institute, Cary, NC, USA) for statistical analysis and significance calculations.

Results {#anae14297-sec-0003}
=======

Table [1](#anae14297-tbl-0001){ref-type="table"} shows the characteristics of patients enrolled in the study. Major trauma, defined as ISS ≥ 15, was recorded in 635 (55%) of the patients.

###### 

Characteristics of 1146 patients included in the study. Values are median (IQR \[range\]) or number (proportion)

  ----------------------------------------------------------------------- ----------------------------------
  Age; years                                                              41 (26--58 \[13--96\])
  Injury severity score                                                   17 (9--26 \[1--75\])
  Sex; male                                                               837 (73.0%)
  Penetrating trauma                                                      196 (17.0%)
  Mechanism                                                               
  Motor vehicle driver/ passenger                                         387 (33.8%)
  Pedestrian/ cyclist                                                     207 (18.1%)
  Fall                                                                    269 (23.5%)
  Industrial (excluding falls)                                            31 (2.7%)
  Stabbing                                                                142 (12.4%)
  Gunshot wound                                                           45 (3.9%)
  Other assault                                                           44 (3.8%)
  Other                                                                   22 (1.9%)
  Died in first 24 h                                                      97 (8.5%)
  Any transfusion in first 24 h                                           172 (15.0%)
  Massive transfusion in first 24 h (\> 9 units packed red blood cells)   21 (1.8%)
  Time, injury to hospital arrival; h                                     1.2 (0.8--4.9 \[0.05--24\])
  Time, hospital arrival to ROTEM; min                                    40 (32--51 \[2.4--390\]).
  Systolic arterial pressure; mmHg                                        142 (126--160 \[0--250\])
  Platelet count; ×10^9^.l^−1^                                            231 (192--275 \[12--545\])
  INR                                                                     1.07 (1.00--1.17 \[0.86--8.63\])
  ----------------------------------------------------------------------- ----------------------------------
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Figures [1](#anae14297-fig-0001){ref-type="fig"} and [2](#anae14297-fig-0002){ref-type="fig"} show the correlation of A5:MCF and A10:MCF, which were both linear and strongly positive. The Pearson correlation coefficients were 0.92 for A5:MCF, and 0.96 for A10:MCF.

![Correlation of A5 and MCF.](ANAE-73-1103-g001){#anae14297-fig-0001}

![Correlation of A10 and MCF.](ANAE-73-1103-g002){#anae14297-fig-0002}

Figure [3](#anae14297-fig-0003){ref-type="fig"} shows the receiver operating characteristic curves for the ROTEM measurements in prediction of mortality. The c‐stat values for correlation with mortality were A5 0.67, A10 0.69 and MCF 0.69.

![Receiver operating characteristic curves for A5, A10 and MCF vs. in‐hospital mortality. Grey solid line -- null effect; dotted line -- A5; short dashes -- A10; long dashes -- MCF.](ANAE-73-1103-g003){#anae14297-fig-0003}

Figure [4](#anae14297-fig-0004){ref-type="fig"} shows the receiver operating characteristic curves for the ROTEM measurements in prediction of massive transfusion. The c‐stat values for correlation with massive transfusion were A5 0.87, A10 0.89 and MCF 0.90.

![Receiver operating characteristic curves for A5, A10 and MCF vs. massive transfusion. Grey solid line -- null effect; dotted line -- A5; short dashes -- A10; long dashes -- MCF.](ANAE-73-1103-g004){#anae14297-fig-0004}

We wished to establish whether cases of massive transfusion would be missed if A5 were used as a predictor instead of A10, which might be affected by the cut‐off values used. Appendix 1 shows the effects of changing cut‐off values for A5 and A10 in predicting massive transfusion.

Discussion {#anae14297-sec-0004}
==========

The strong correlation of both A5 and A10 with MCF indicate that either of these early clotting measures is acceptable as an early substitute in decision making. However, A5 and A10 need not be seen only as surrogates for MCF. To our knowledge, although the correlation of A5 and A10 with MCF has been studied [11](#anae14297-bib-0011){ref-type="ref"}, MCF has not yet been demonstrated as superior to A5 or A10 for predicting clinical outcome.

Generally models are considered reasonable when c‐stat exceeds 0.7, and strong if it exceeds 0.8 [17](#anae14297-bib-0017){ref-type="ref"}. Although not exactly the same, the c‐stat for A5, A10 and MCF vs. massive transfusion all indicate similarly strong models; in other words, all three clot firmness measures are similarly and strongly predictive of the requirement for massive transfusion. Despite the slight variance in c‐stat values, in no case did using A5 miss cases of massive transfusion, compared with A10. In fact, depending on the cut‐off used, A5 identified some cases of massive transfusion that would have been missed using A10.

Although the c‐stats for A5, A10 and MCF vs. mortality do not indicate a strong model, the values are similar. Therefore, even if these measures were combined with others as part of a multivariate model or scoring system, there would be little or no advantage in using MCF compared with A5 or A10.

There is some evidence that TEG and ROTEM are useful in predicting transfusion requirements and survival [5](#anae14297-bib-0005){ref-type="ref"}, [18](#anae14297-bib-0018){ref-type="ref"}, [19](#anae14297-bib-0019){ref-type="ref"}, [20](#anae14297-bib-0020){ref-type="ref"}, and in guiding resuscitation [2](#anae14297-bib-0002){ref-type="ref"}, [21](#anae14297-bib-0021){ref-type="ref"}, [22](#anae14297-bib-0022){ref-type="ref"}, [23](#anae14297-bib-0023){ref-type="ref"}, [24](#anae14297-bib-0024){ref-type="ref"}, [25](#anae14297-bib-0025){ref-type="ref"}, with some reports of favourable outcomes [26](#anae14297-bib-0026){ref-type="ref"}, [27](#anae14297-bib-0027){ref-type="ref"}. However, the most recent Cochrane review in 2015 concluded "...*evidence strongly suggests that at present these tests should only be used for research*" [28](#anae14297-bib-0028){ref-type="ref"}. Although algorithms have been developed to aid decision making based on ROTEM measures [29](#anae14297-bib-0029){ref-type="ref"}, there remains a question mark over the appropriate diagnostic thresholds to use. One review [30](#anae14297-bib-0030){ref-type="ref"} noted that the best‐designed study in terms of predicting transfusion using ROTEM measures was by Davenport et al. in 2011 [31](#anae14297-bib-0031){ref-type="ref"}, using a cut‐off value of A5 \< 35 mm.

The appropriate cut‐off value for A5 in fact depends on what weight it is given in the decision‐making process. Our data show a high sensitivity and specificity for the previously published cut‐off value of A5 \< 35 mm [29](#anae14297-bib-0029){ref-type="ref"}, but the positive predictive value at 9% is low. This may be an appropriate threshold to inform a multi‐variate analysis, or add support to triggering a massive transfusion protocol in view of an overall clinical picture. However, given the resource implications, a lower threshold of A5 \< 29 mm with a positive predictive value of 20%, or A5 \< 30 mm with a positive predictive value of 18%, may be more pragmatic if triggering a massive transfusion protocol purely on the basis of one ROTEM measure.

In summary, ROTEM EXTEM A5 is as useful clinically as A10 and MCF in making early treatment decisions in bleeding following trauma, for example, triggering a massive transfusion protocol. This is in line with the results of a recent international multi‐centre prospective study [32](#anae14297-bib-0032){ref-type="ref"}. A5 is a useful early measure of clot firmness, and with appropriate selection of the cut‐off value, can be strongly predictive of requirement for massive transfusion.
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###### 

Characteristics of populations defined by different cut‐off values for A5, where predicted event is massive transfusion (21 cases)

  A5 (mm)   Positive test   \% testing positive   TP   FP    TN     FN   Sensitivity   Specificity   PPV    NPV    Youden\'s index
  --------- --------------- --------------------- ---- ----- ------ ---- ------------- ------------- ------ ------ -----------------
  \< 20     29              2.5                   10   19    1106   11   0.48          0.98          0.34   0.99   0.46
  \< 21     31              2.7                   10   21    1104   11   0.48          0.98          0.32   0.99   0.46
  \< 22     32              2.8                   10   22    1103   11   0.48          0.98          0.31   0.99   0.46
  \< 23     35              3.1                   11   24    1101   10   0.52          0.98          0.31   0.99   0.50
  \< 24     43              3.7                   12   31    1094   9    0.57          0.97          0.28   0.99   0.54
  \< 25     49              4.1                   14   35    1090   7    0.67          0.97          0.29   0.99   0.64
  \< 26     52              4.5                   14   38    1087   7    0.67          0.97          0.27   0.99   0.63
  \< 27     55              4.8                   14   41    1084   7    0.67          0.96          0.25   0.99   0.63
  \< 28     64              5.6                   14   50    1075   7    0.67          0.96          0.22   0.99   0.62
  \< 29     69              6.0                   14   55    1070   7    0.67          0.95          0.20   0.99   0.62
  \< 30     78              6.8                   14   64    1061   7    0.67          0.94          0.18   0.99   0.61
  \< 31     93              8.1                   14   79    1046   7    0.67          0.93          0.15   0.99   0.60
  \< 32     113             9.9                   15   98    1027   6    0.71          0.91          0.13   0.99   0.63
  \< 33     139             12.1                  18   121   1004   3    0.86          0.89          0.13   1.00   0.75
  \< 34     178             15.5                  18   160   965    3    0.86          0.86          0.10   1.00   0.71
  \< 35     214             18.7                  20   194   931    1    0.95          0.83          0.09   1.00   0.78
  \< 36     255             22.2                  20   235   890    1    0.95          0.79          0.08   1.00   0.74
  \< 37     306             26.7                  21   285   840    0    1.00          0.75          0.07   1.00   0.75

TP, true positive; FP, false negative; TN, true negative; FN, false negative; PPV, positive predictive value, NPV, negative predictive value; Youden\'s index = (sensitivity + specificity) --1.
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###### 

Characteristics of populations defined by different cut‐off values for A10, where predicted event is massive transfusion (21 cases)

  A10     Positive test   \% testing positive   TP   FP    TN     FN   Sensitivity   Specificity   PPV    NPV    Youden\'s index
  ------- --------------- --------------------- ---- ----- ------ ---- ------------- ------------- ------ ------ -----------------
  \< 25   25              2.2                   8    17    1108   13   0.38          0.98          0.32   0.99   0.37
  \< 26   26              2.3                   8    18    1107   13   0.38          0.98          0.31   0.99   0.36
  \< 27   26              2.3                   8    18    1107   13   0.38          0.98          0.31   0.99   0.36
  \< 28   27              2.4                   8    19    1106   13   0.38          0.98          0.30   0.99   0.36
  \< 29   30              2.6                   8    22    1103   13   0.38          0.98          0.27   0.99   0.36
  \< 30   34              3.0                   8    26    1099   13   0.38          0.98          0.24   0.99   0.36
  \< 31   34              3.0                   8    26    1099   13   0.38          0.98          0.24   0.99   0.36
  \< 32   37              3.2                   10   27    1098   11   0.48          0.98          0.27   0.99   0.45
  \< 33   43              3.8                   10   33    1092   11   0.48          0.97          0.23   0.99   0.45
  \< 34   50              4.4                   11   39    1086   10   0.52          0.97          0.22   0.99   0.49
  \< 35   54              4.7                   11   43    1082   10   0.52          0.96          0.20   0.99   0.49
  \< 36   55              4.8                   11   44    1081   10   0.52          0.96          0.20   0.99   0.48
  \< 37   59              5.1                   12   47    1078   9    0.57          0.96          0.20   0.99   0.53
  \< 38   65              5.7                   13   52    1073   8    0.62          0.95          0.20   0.99   0.57
  \< 39   76              6.6                   13   63    1062   8    0.62          0.94          0.17   0.99   0.56
  \< 40   80              7.0                   13   67    1058   8    0.62          0.94          0.16   0.99   0.56
  \< 41   88              7.7                   13   75    1050   8    0.62          0.93          0.15   0.99   0.55
  \< 42   104             9.1                   14   90    1035   7    0.67          0.92          0.13   0.99   0.59
  \< 43   123             10.7                  15   108   1017   6    0.71          0.90          0.12   0.99   0.62
  \< 44   152             13.3                  16   136   989    5    0.76          0.88          0.11   0.99   0.64
  \< 45   183             16.0                  18   165   960    3    0.86          0.85          0.10   1.00   0.71
  \< 46   225             19.6                  18   207   918    3    0.86          0.82          0.08   1.00   0.67
  \< 47   267             23.3                  19   248   877    2    0.90          0.78          0.07   1.00   0.68
  \< 48   317             27.7                  19   298   827    2    0.90          0.74          0.06   1.00   0.64
  \< 49   361             31.5                  19   342   783    2    0.90          0.70          0.05   1.00   0.60
  \< 50   415             36.3                  19   396   729    2    0.90          0.65          0.05   1.00   0.55

TP, true positive; FP, false negative; TN, true negative; FN, false negative; PPV, positive predictive value, NPV, negative predictive value; Youden\'s index = (sensitivity + specificity) --1.
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